0001213900-19-009295.txt : 20190521
0001213900-19-009295.hdr.sgml : 20190521
20190521135801
ACCESSION NUMBER: 0001213900-19-009295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20190521
DATE AS OF CHANGE: 20190521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bison Capital Holding Co Ltd
CENTRAL INDEX KEY: 0001593415
STATE OF INCORPORATION: F4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38120
FILM NUMBER: 19841823
BUSINESS ADDRESS:
STREET 1: 609-610, 21ST CENTURY TOWER
STREET 2: 40 LIANGMAQIAO RD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100016
BUSINESS PHONE: 8618610840084
MAIL ADDRESS:
STREET 1: 609-610, 21ST CENTURY TOWER
STREET 2: 40 LIANGMAQIAO RD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001697805
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 609-610 21ST CENTURY TOWER
STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100016
BUSINESS PHONE: 9493506999
MAIL ADDRESS:
STREET 1: 609-610 21ST CENTURY TOWER
STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100016
FORMER COMPANY:
FORMER CONFORMED NAME: Bison Capital Acquisition Corp.
DATE OF NAME CHANGE: 20170621
FORMER COMPANY:
FORMER CONFORMED NAME: Bison Capital Acquisition Corp
DATE OF NAME CHANGE: 20170209
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2019-05-15
0
0001697805
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
XYN
0001593415
Bison Capital Holding Co Ltd
SUITE 3306, K. WAH CENTRE,
1010 MIDDLE HUAIHAI ROAD
SHANGHAI
F4
200031
CHINA
0
0
0
1
Former 10% more owner
Common Stock, par value $0.0001 per share
2019-05-15
4
P
0
108980
A
1628580
D
Warrants
11.5
2019-05-15
4
P
0
25000
11.50
A
Common Stock
25000
225937
D
In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 13,793 shares (the "Backstop Shares") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the "Company"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share.
Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination.
Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019.
/s/ Peixin Xu
2019-05-21